HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Wehrli Selected Research

Heparin (Liquaemin)

8/2001[Low molecular weight heparin (dalteparin) in treatment of patients with thromboembolism incidents].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Wehrli Research Topics

Disease

1Body Weight (Weight, Body)
08/2001
1Embolism (Embolus)
08/2001
1Hemorrhage
08/2001
1Thrombocytopenia (Thrombopenia)
08/2001
1Thromboembolism
08/2001
1Thrombosis (Thrombus)
08/2001
1Embolism and Thrombosis
08/2001
1Sepsis (Septicemia)
08/2001
1Venous Thrombosis (Deep-Vein Thrombosis)
08/2001

Drug/Important Bio-Agent (IBA)

1Heparin (Liquaemin)FDA LinkGeneric
08/2001
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
08/2001
1Dalteparin (Dalteparin Sodium)FDA Link
08/2001

Therapy/Procedure

1Catheters
08/2001